FDA, J&J Near Deal for Covid-19 Vaccine Production at Baltimore Plant

Johnson & Johnson and the FDA expect to announce as early as Friday that contamination problems at the plant are resolved, clearing the way for millions more doses to become available.

Jump To The Original Source

Share this Story
Load More Related Articles
Load More In US News

Facebook Comments

Check Also

U.N. readies for more displaced Afghans after troop withdrawal

Published by Reuters By Michelle Nichols UNITED NATIONS ...

Archives